BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 37661300)

  • 1. Frontline Hyper-CVAD Plus Venetoclax for Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm.
    He J; Garcia MB; Connors JS; Nuñez CA; Quesada AE; Gibson A; Roth M; Cuglievan B; Pemmaraju N; McCall D
    J Pediatr Hematol Oncol; 2023 Nov; 45(8):e1001-e1004. PubMed ID: 37661300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Jain A; Sweet K
    J Natl Compr Canc Netw; 2023 May; 21(5):515-521. PubMed ID: 37156483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tagraxofusp followed by combined azacitidine and venetoclax in blastic plasmacytoid dendritic cell neoplasm: A case report and literature review.
    Samhouri Y; Ursu S; Dutton N; Tanvi V; Fazal S
    J Oncol Pharm Pract; 2021 Jun; 27(4):990-995. PubMed ID: 32847479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blastic Plasmacytoid Dendritic Cell Neoplasm: A Comprehensive Review of the Disease, Central Nervous System Presentations, and Treatment Strategies.
    Mehra S; Taylor J
    Cells; 2024 Jan; 13(3):. PubMed ID: 38334635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose venetoclax combined with azacitidine for blastic plasmacytoid dendritic cell neoplasm: a case report and literature review.
    Wang Q; Zhao Y; Zang X; Zhou G; Liu Y; Feng Q; Li X; Wang W; Dong X; Liu X; Peng J; Liu C
    Ann Hematol; 2024 Mar; 103(3):999-1005. PubMed ID: 38285081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel treatment of blastic plasmacytoid dendritic cell neoplasm: A case report.
    Grushchak S; Joy C; Gray A; Opel D; Speiser J; Reserva J; Tung R; Smith SE
    Medicine (Baltimore); 2017 Dec; 96(51):e9452. PubMed ID: 29390581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Therapeutic Approaches in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Era of Targeted Therapy.
    Wilson NR; Konopleva M; Khoury JD; Pemmaraju N
    Clin Lymphoma Myeloma Leuk; 2021 Nov; 21(11):734-740. PubMed ID: 34226167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Blastic plasmacytoid dendritic cell tumor treated with DVT regimen: a case report and literature review].
    Shi J; Xu N; Niu Y; Jia SX; Yang CM; Fang MY
    Zhonghua Xue Ye Xue Za Zhi; 2024 Jan; 45(1):86-89. PubMed ID: 38527844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Case of Cutaneous Blastic Plasmacytoid Dendritic Cell Neoplasm Treated With a Bcl-2 Inhibitor.
    Egger A; Coello D; Kirsner RS; Brehm JE
    J Drugs Dermatol; 2021 May; 20(5):550-551. PubMed ID: 33938687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical Characteristics and Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm].
    Zhang XL; Liu B; Li N; Li LK; Ji XJ; Zhou XF; Wang MF; Xu HL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):254-260. PubMed ID: 36765508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venetoclax in relapsed/refractory blastic plasmacytoid dendritic cell neoplasm with central nervous system involvement: a case report and review of the literature.
    Albiol N; Novelli S; Mozos A; Pratcorona M; Martino R; Sierra J
    J Med Case Rep; 2021 Jun; 15(1):326. PubMed ID: 34172079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and outcomes of patients with blastic plasmacytoid dendritic cell neoplasm treated with frontline HCVAD.
    Pemmaraju N; Wilson NR; Garcia-Manero G; Sasaki K; Khoury JD; Jain N; Borthakur G; Ravandi F; Daver N; Kadia T; DiNardo C; Jabbour E; Pierce S; Qazilbash M; Konopleva M; Kantarjian H
    Blood Adv; 2022 May; 6(10):3027-3035. PubMed ID: 35061885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blastic plasmacytoid dendritic cell neoplasm (BPDCN): a rare entity.
    Lim MS; Lemmert K; Enjeti A
    BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26791132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations.
    Shumilov E; Mazzeo P; Ghandili S; Künstner A; Weidemann S; Banz Y; Ströbel P; Pollak M; Kolloch L; Beltraminelli H; Kerkhoff A; Mikesch JH; Schliemann C; Haase D; Wulf G; Legros M; Lenz G; Feldmeyer L; Pabst T; Witte H; Gebauer N; Bacher U
    Ann Hematol; 2024 May; 103(5):1587-1599. PubMed ID: 38194088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyper-CVAD combined with Venetoclax for relapsed pediatric blastic plasmacytoid dendritic cell neoplasm (BPDCN): A case report and literature review.
    Abla D; Abboud MR; Noun D; Tarek N; Pemmaraju N
    Leuk Res Rep; 2022; 17():100313. PubMed ID: 35462725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological analysis of 46 cases with CD4
    Suzuki Y; Kato S; Kohno K; Satou A; Eladl AE; Asano N; Kono M; Kato Y; Taniwaki M; Akiyama M; Nakamura S
    Histopathology; 2017 Dec; 71(6):972-984. PubMed ID: 28795410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies.
    Cuglievan B; Connors J; He J; Khazal S; Yedururi S; Dai J; Garces S; Quesada AE; Roth M; Garcia M; McCall D; Gibson A; Ragoonanan D; Petropoulos D; Tewari P; Nunez C; Mahadeo KM; Tasian SK; Lamble AJ; Pawlowska A; Hammond D; Maiti A; Haddad FG; Senapati J; Daver N; Gangat N; Konopleva M; Meshinchi S; Pemmaraju N
    Leukemia; 2023 Sep; 37(9):1767-1778. PubMed ID: 37452102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blastic Plasmacytoid Dendritic Cell Neoplasm with Pulmonary Involvement and Atypical Skin Lesion.
    Barros Romão CMDS; Santos Júnior CJD; Leite LAC; Gomes Alves MJR; Araújo NS; Castro AFL; Moura MS; Gomes VMDS; Sampaio Batinga AMC; Queiroz JAS; Dos Santos NB
    Am J Case Rep; 2017 Jun; 18():692-695. PubMed ID: 28635683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomal Daunorubicin and Cytarabine, a Potential Therapy for Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Ashok Kumar P; Ombada M; Pemmasani G; Tambe A; Banki K; Gentile T
    J Investig Med High Impact Case Rep; 2022; 10():23247096221127114. PubMed ID: 36341907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding the Immunophenotypic Spectrum of Neoplastic and Reactive Plasmacytoid Dendritic Cells.
    Wu SJ; Sadigh S; Lane AA; Pinkus GS
    Am J Clin Pathol; 2023 May; 159(5):455-463. PubMed ID: 36880313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.